PLX - Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03 revenue of $10.35M beats by $2.71M
2023-11-06 06:53:00 ET
More on Protalix BioTherapeutics
- Protalix BioTherapeutics Stock Is A Hold Pending Successful Commercialization Of Elfabrio
- Nano-X, InMode, Teva among notable Israel-based healthcare decliners
- Seeking Alpha’s Quant Rating on Protalix BioTherapeutics
- Historical earnings data for Protalix BioTherapeutics
- Financial information for Protalix BioTherapeutics
For further details see:
Protalix BioTherapeutics GAAP EPS of -$0.04 beats by $0.03, revenue of $10.35M beats by $2.71M